Log in

Relevant bibliographies by topics / Targetting / Journal articles

To see the other types of publications on this topic, follow the link: Targetting.

Journal articles on the topic 'Targetting'

Author: Grafiati

Published: 4 June 2021

Last updated: 17 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Targetting.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Assadoorian, Alice. "Targetting Iran." Iran and the Caucasus 12, no. 2 (2008): 401–6. http://dx.doi.org/10.1163/157338408x406155.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Rivera-Nieves, Jesus, Martin Oppermann, and Fabio Cominelli. "Targetting CCL25/CCR9." American Journal of Gastroenterology 101 (September 2006): S446. http://dx.doi.org/10.14309/00000434-200609001-01142.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Higgins, Gill. "Targetting cytokines in rheumatology." Inpharma Weekly &NA;, no. 851 (1992): 3–5. http://dx.doi.org/10.2165/00128413-199208510-00004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Salter, A. E., M. T. Sharratt, and K. Bookan. "TARGETTING RURAL CARDIAC PATIENTS." Medicine & Science in Sports & Exercise 35, Supplement 1 (2003): S214. http://dx.doi.org/10.1097/00005768-200305001-01184.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Hill, Robert. "RELIABILITY ANALYSIS, MODELLING, AND TARGETTING." JOURNAL OF THE MARINE ENGINEERING SOCIETY IN JAPAN 30, no. 11 (1995): 743–54. http://dx.doi.org/10.5988/jime1966.30.743.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

&NA;. "Targetting CD6 effectively prevents GVHD." Inpharma Weekly &NA;, no. 922 (1994): 9. http://dx.doi.org/10.2165/00128413-199409220-00019.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

BRYANT, J. "Targetting proteins into subcellular organelles." Trends in Biotechnology 3, no. 6 (1985): 133. http://dx.doi.org/10.1016/0167-7799(85)90100-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Porter, K. E., A. B. Hinchliffe, and J. Pardoe. "Targetting membranes for gas separation." Gas Separation & Purification 4, no. 4 (1990): 185–89. http://dx.doi.org/10.1016/0950-4214(90)80040-r.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Phillips, James G., Mark A. Bellgrove, and John L. Bradshaw. "Predicting relationships between speed and accuracy of targetting movements is important." Behavioral and Brain Sciences 20, no. 2 (1997): 319–20. http://dx.doi.org/10.1017/s0140525x97391444.

Full text

Abstract:

While explaining a large proportion of any variance, accounts of the speed and accuracy of targetting movements use techniques (e.g., log transforms) that typically reduce variability before “explaining” the data. Therefore the predictive power of such accounts are important. We consider whether Plamondon's model can account for kinematics of targetting movements of clinical populations.

APA, Harvard, Vancouver, ISO, and other styles

10

&NA;. "DNA-targetting hits hypoxic tumour cells." Inpharma Weekly &NA;, no. 889 (1993): 12. http://dx.doi.org/10.2165/00128413-199308890-00026.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

&NA;. "Targetting AUIC for better ciprofloxacin response." Inpharma Weekly &NA;, no. 890 (1993): 19. http://dx.doi.org/10.2165/00128413-199308900-00046.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

ITOH, Hiroko, Takeshi MATSUOKA, and Mitsutoyo OKADA. "PSC Targetting System with Discriminant Analysis." Journal of Japan Institute of Navigation 112 (2005): 57–62. http://dx.doi.org/10.9749/jin.112.57.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Ysebaert, Loïc, та Marie-Sarah Dilhuydy. "Targetting BTK/PI-3Kδ in CLL". Hématologie 21, № 2 (2015): 117–26. http://dx.doi.org/10.1684/hma.2015.1012.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

&NA;. "Targetting cancers with bifunctional monoclonal antibodies." Inpharma Weekly &NA;, no. 854 (1992): 9. http://dx.doi.org/10.2165/00128413-199208540-00016.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Charny, M. C., and S. C. Farrow. "Risk targetting: an approach to costcontainment." Health Policy 6, no. 4 (1986): 363–72. http://dx.doi.org/10.1016/0168-8510(86)90051-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Singh, G., and S. N. Sharma. "Targetting of piperazine complexes in ascariasis." European Journal of Pharmacology 183, no. 4 (1990): 1201–2. http://dx.doi.org/10.1016/0014-2999(90)94295-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Gidley, Jennifer M. "An Intervention Targetting Hopelessness in Adolescents by Promoting Positive Future Images." Journal of Psychologists and Counsellors in Schools 11 (November 2001): 51–64. http://dx.doi.org/10.1017/s1037291100004337.

Full text

Abstract:

This paper presents some ground-work for the development of a new theoretical approach which has the potential to contribute to primary prevention of suicide in adolescents by targetting hopelessness. Drawing on the extensive psychological literature which has linked hopelessness with depression and suicide risk for decades, the author notes that although there is a strong research and clinical base for targetting depression, there is a gap in the psychological literature when it comes to targetting hopelessness, specifically. Looking beyond the psychology field to the futures studies research

APA, Harvard, Vancouver, ISO, and other styles

18

&NA;. "Targetting adverse effects of steroids in children." Reactions Weekly &NA;, no. 453 (1993): 4. http://dx.doi.org/10.2165/00128415-199304530-00008.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Goldie, Stephen, Scott Lyons, Richard Price, and Fiona Watt. "Targetting stem cells in squamous cell carcinoma." International Journal of Surgery 10, no. 8 (2012): S7. http://dx.doi.org/10.1016/j.ijsu.2012.06.040.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Le Pape, A., C. Jubault, R. Barot-Clorbaru, M. Musset, and G. Mathé. "Targetting of immunocompetent cells for tumour scintigraphy." International Journal of Immunopharmacology 10 (January 1988): 29. http://dx.doi.org/10.1016/0192-0561(88)90229-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Takashima, Akihiko. "Targetting tau aggregation as therapy of dementia." Neuroscience Research 68 (January 2010): e28. http://dx.doi.org/10.1016/j.neures.2010.07.363.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Murray, R. F., B. R. Beutter, M. P. Eckstein, and L. S. Stone. "Saccadic targetting during visual search for letters." Journal of Vision 2, no. 10 (2002): 21. http://dx.doi.org/10.1167/2.10.21.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Rotundo, Richard L., Sasana G. Rossi, and H. Benjamin Peng. "Targetting acetylcholinesterase molecules to the neuromuscular synapse." Journal of Physiology-Paris 92, no. 3-4 (1998): 195–98. http://dx.doi.org/10.1016/s0928-4257(98)80009-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Fiory, Francesca, Rosa Spinelli, Gregory Alexander Raciti, et al. "Targetting PED/PEA-15 for diabetes treatment." Expert Opinion on Therapeutic Targets 21, no. 6 (2017): 571–81. http://dx.doi.org/10.1080/14728222.2017.1317749.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Hudson, I. "Locking nailing: an aid to distal targetting." Injury 20, no. 3 (1989): 129–30. http://dx.doi.org/10.1016/0020-1383(89)90080-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Schaefer, H. "Targetting: how to direct the drug disease." Journal of the European Academy of Dermatology and Venereology 5, no. 1 (1995): S70. http://dx.doi.org/10.1016/0926-9959(95)96021-y.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Hemminki, Elina, and Mika Gissler. "Quantity and targetting of antenatal care in Finland." Acta Obstetricia et Gynecologica Scandinavica 72, no. 1 (1993): 24–30. http://dx.doi.org/10.3109/00016349309013344.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Norguet, Emmanuelle, Laetitia Dahan, and Jean-Francois Seitz. "Targetting Esophageal and Gastric Cancers with Monoclonal Antibodies." Current Topics in Medicinal Chemistry 12, no. 15 (2012): 1678–82. http://dx.doi.org/10.2174/156802612803531360.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Mattei, D., A. Ivanov, G. Ferrai, et al. "Targetting microglia activation in schizophrenia by minocycline treatment." European Neuropsychopharmacology 26 (October 2016): S134. http://dx.doi.org/10.1016/s0924-977x(16)30922-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Angus, James A., Christine E. Wright, and Qi Xi. "Targetting voltage-gated calcium channels in cardiovascular therapy." Lancet 356, no. 9238 (2000): 1287–89. http://dx.doi.org/10.1016/s0140-6736(00)02807-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Ryan, Michael J. "Data envelopment analysis, cost efficiency and performance targetting." Journal of Information and Optimization Sciences 23, no. 2 (2002): 241–58. http://dx.doi.org/10.1080/02522667.2002.10698994.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Angrand, P. O., N. Daigle, F. van der Hoeven, H. R. Scholer, and A. F. Stewart. "Simplified generation of targetting constructs using ET recombination." Nucleic Acids Research 27, no. 17 (1999): i—vi. http://dx.doi.org/10.1093/nar/27.17.e16-i.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Parker, D., J. R. Morphy, Karl Jankowski, and Jonathan Cox. "Implementation of macrocycle conjugated antibodies for tumour-targetting." Pure and Applied Chemistry 61, no. 9 (1989): 1637–41. http://dx.doi.org/10.1351/pac198961091637.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Booth, Andrew G. "Targetting student support in large first year classes." Biochemical Education 22, no. 4 (1994): 199–200. http://dx.doi.org/10.1016/0307-4412(94)90008-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Lamshöft, Kevin, and Jana Dittmann. "Assessment of Hidden Channel Attacks: Targetting Modbus/TCP." IFAC-PapersOnLine 53, no. 2 (2020): 11100–11107. http://dx.doi.org/10.1016/j.ifacol.2020.12.258.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Baltuch, Gordon H., Nora P. Dooley, Jean-Guy Villemure, and Voon Wee Yong. "Protein Kinase C and Growth Regulation of Malignant Gliomas." Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 22, no. 4 (1995): 264–71. http://dx.doi.org/10.1017/s0317167100039457.

Full text

Abstract:

AbstractThis article reviews the role of the signal transduction enzyme protein kinase C in the regulation of growth of malignant gliomas, and describes how targetting this enzyme clinically can provide a novel approach to glioma therapy.

APA, Harvard, Vancouver, ISO, and other styles

37

Fukumoto, Tetsuya, Kazutoshi Nomura, Noburo Hashimoto, Mako Hirano, Hiroshi Teramoto, and Kazuhiro Katahira. "Coronal oblique view of MRI targetting anterior cruciate ligament." Orthopedics & Traumatology 46, no. 2 (1997): 526–30. http://dx.doi.org/10.5035/nishiseisai.46.526.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Bonthagarala, Brahmaiah, Shabana P., Abbaraju Lakshmi Harini, and Varun Dasari. "Nasal Drug Delivery: A Potential Route for Brain Targetting." International Journal of Advances in Scientific Research 1, no. 2 (2015): 65. http://dx.doi.org/10.7439/ijasr.v1i2.1782.

Full text

Abstract:

Present review highlights the potential of nasal mucosa as an administration route for targeting the centralnervous system, the brain. Targeted drug delivery seeks to concentrate the medication in the tissues ofinterest while reducing the relative concentration of medication in the remaining tissues. Thus improvingefficacy of the drug and reducing side effects. The nasal mucosa when compared to other mucousmembranes is easily accessible and provides a practical entrance portal for small and large molecules.Intranasal administration offers rapid onset of action, no first-pass effect, no gastroi

APA, Harvard, Vancouver, ISO, and other styles

39

&NA;. "Targetting both activated and quiescent cells to beat HIV." Inpharma Weekly &NA;, no. 879 (1993): 13. http://dx.doi.org/10.2165/00128413-199308790-00028.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Masood, Aetsam, Mahmood Kayani, and Sajida Batool. "Targetting Interleukins Involved in Glioblastoma – A New Pharmacological Approach." Journal of Life and Bio Sciences Research 1, no. 3 (2020): 82–88. http://dx.doi.org/10.38094/jlbsr1330.

Full text

Abstract:

Brain tumor is unchecked growth of brain cells disrupting many of its important functions and, affecting molecular regulatory and signaling networks. Glioblastoma is one of the most deleterious tumors of human brain. Cytokines are secondary messenger molecules in many of the immunological and other biochemical reactions. With glioblastoma progression, various cytokines are secreted that either up-regulate or down-regulate many others with immunological function. Interleukins are a family of cytokines acting mainly as immune-regulatory proteins. They have been implicated in brain tumor initiati

APA, Harvard, Vancouver, ISO, and other styles

41

Dr. Sunayna Khurana et al.,, Dr Sunayna Khurana et al ,. "Food Advertising Targetting Young Consumers- What Do Parents Think." International Journal of Mechanical and Production Engineering Research and Development 10, no. 3 (2020): 12983–90. http://dx.doi.org/10.24247/ijmperdjun20201240.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Fujita, Tadao. "Using CAD to design receptor targetting of potent drugs." Computer-Aided Design 19, no. 2 (1987): 91–94. http://dx.doi.org/10.1016/s0010-4485(87)80051-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Wilhelm, K., B. Kotze, K. Arnold, B. Hudson, and A. Macloughlainn. "Targetting delirium: A hospital wide C/L psychiatry initiative." Australian and New Zealand Journal of Psychiatry 34, s1 (2000): A71. http://dx.doi.org/10.1080/000486700808.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Miyazaki, Tomoyuki, Waki Nakajima, Tetsu Arisawa, and Takuya Takahashi. "The development of novel anti-depressant targetting AMPA receptor." Proceedings for Annual Meeting of The Japanese Pharmacological Society 92 (2019): 1—YIA—02. http://dx.doi.org/10.1254/jpssuppl.92.0_1-yia-02.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Sharma, R. A. "Translational medicine: targetting cyclo-oxygenase isozymes to prevent cancer." QJM 95, no. 5 (2002): 267–73. http://dx.doi.org/10.1093/qjmed/95.5.267.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Thygesen, Kristian, and Allan S. Jaffe. "Detecting myocardial infarction type 2: targetting the right patients." European Heart Journal 38, no. 47 (2017): 3521–22. http://dx.doi.org/10.1093/eurheartj/ehx557.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Fahy and Boushey. "Targetting IgE with monoclonal antibodies: the future is now." Clinical & Experimental Allergy 28, no. 6 (1998): 664–67. http://dx.doi.org/10.1046/j.1365-2222.1998.00290.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Parkinson, David R. "The Biological Therapy of Cancer." Canadian Journal of Infectious Diseases 3, suppl b (1992): 26–33. http://dx.doi.org/10.1155/1992/420495.

Full text

Abstract:

The current status of biological approaches to the therapy of malignancy is reviewed. Biological response modifiers have been used in immunobiological therapeutic strategies, as myelorestorative agents during chemotherapy, as modulators of cytotoxic chemotherapeutic actions, and as adjuncts to the differentiation therapy of cancer. Immunobiologically active agents currently under study include recombinant cytokines such as interferons-alpha and -gamma. interleukin (IL)-1 and IL-2. and tumuor necrosis factor. A range of hematopoietic growth factors are being studied alone or in combination; the

APA, Harvard, Vancouver, ISO, and other styles

49

Matthews, Alexandra L., Justyna Szyroka, Richard Collier, Peter J. Noy, and Michael G. Tomlinson. "Scissor sisters: regulation of ADAM10 by the TspanC8 tetraspanins." Biochemical Society Transactions 45, no. 3 (2017): 719–30. http://dx.doi.org/10.1042/bst20160290.

Full text

Abstract:

A disintegrin and metalloprotease 10 (ADAM10) is a ubiquitously expressed transmembrane protein which is essential for embryonic development through activation of Notch proteins. ADAM10 regulates over 40 other transmembrane proteins and acts as a ‘molecular scissor’ by removing their extracellular regions. ADAM10 is also a receptor for α-toxin, a major virulence factor of Staphylococcus aureus. Owing to the importance of its substrates, ADAM10 is a potential therapeutic target for cancer, neurodegenerative diseases such as Alzheimer's and prion diseases, bacterial infection and inflammatory di

APA, Harvard, Vancouver, ISO, and other styles

50

León-Triana, Odelaisy, Antonio Pérez-Martínez, Manuel Ramírez-Orellana, and Víctor M. Pérez-García. "Dual-Target CAR-Ts with On- and Off-Tumour Activity May Override Immune Suppression in Solid Cancers: A Mathematical Proof of Concept." Cancers 13, no. 4 (2021): 703. http://dx.doi.org/10.3390/cancers13040703.

Full text

Abstract:

Chimeric antigen receptor (CAR)-T cell-based therapies have achieved substantial success against B-cell malignancies, which has led to a growing scientific and clinical interest in extending their use to solid cancers. However, results for solid tumours have been limited up to now, in part due to the immunosuppressive tumour microenvironment, which is able to inactivate CAR-T cell clones. In this paper we put forward a mathematical model describing the competition of CAR-T and tumour cells, taking into account their immunosuppressive capacity. Using the mathematical model, we show that the use

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!